NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation
Rhea-AI Summary
NewGenIVF (Nasdaq: NIVF) agreed to make an initial US$2 million strategic investment in AI-powered prediction platform K25.ai, at a US$100 million pre-money valuation, with an option to invest up to US$10 million.
NewGenIVF will also become K25.ai’s exclusive APAC agency partner in selected permitted markets and may earn commissions on gross profit from customers it introduces. K25.ai will nominate three independent non-executive director candidates, potentially expanding NewGenIVF’s board from five to eight members.
Positive
- Initial US$2 million investment at K25.ai US$100 million pre-money valuation
- Option to increase total K25.ai investment up to US$10 million
- Exclusive APAC agency rights in Thailand, Singapore, Japan and other permitted markets
- Commission-based revenue opportunity tied to gross profit from referred customers
- Potential expansion of NewGenIVF board from five to eight directors with three independent nominees
Negative
- Investment and option exercise subject to definitive agreements, closing conditions and regulatory requirements
- Commercial rollout of K25.ai limited to legally permitted APAC markets only
- K25.ai excluded from Mainland China, Hong Kong, Macau and other restricted jurisdictions
- Commission revenues depend on NewGenIVF successfully introducing and servicing K25.ai customers
News Market Reaction – NIVF
In the May 21 session, NIVF gained 51.54%, reflecting a significant positive market reaction. Argus tracked a peak move of +87.2% during that session. Our momentum scanner triggered 24 alerts that day, indicating elevated trading interest and price volatility. Trading volume was exceptionally heavy at 34.2x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 04 | Earnings and strategy | Positive | -1.2% | Reported 2025 results, profit, asset growth and share repurchase authorization. |
| Apr 01 | Annual report filing | Neutral | -4.4% | Filed 2025 Form 20-F annual report for regulatory transparency. |
| Mar 02 | Health initiative MOU | Positive | -5.7% | Signed MOU for regional women’s health awareness and education campaign. |
| Feb 24 | Strategy recap | Positive | +1.5% | Outlined diversification, net assets of US$28M and digital/token plans. |
| Feb 04 | Tokenized bond launch | Positive | -30.4% | Activated commitment campaign for inaugural tokenized real estate bond. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows NIVF often trading down on news, including earnings and strategic updates, with only one positive price reaction among the last five events. Even announcements highlighting net asset growth, diversification, and tokenization initiatives saw selling pressure, and one financing-related milestone coincided with a sharp decline, suggesting a tendency for investors to fade company announcements.
Over the last six months, NIVF reported fiscal 2025 results with US$32.7 million in assets and US$9.9 million net profit, supported by a US$19.2 million bargain purchase gain and a US$2 million repurchase program (May 4, 2026). It also advanced diversification with digital and tokenization initiatives, including a tokenized real estate bond campaign on Feb 4, 2026. Despite these seemingly positive strategic steps, share price reactions were mostly negative, framing today’s AI investment within a pattern of skeptical market responses.
Key Terms
prediction markets financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Initial US
BANGKOK and SINGAPORE, May 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGenIVF” or the “Company”), a technology-driven, diversified growth company, today announced that it has entered into a strategic investment agreement with K25.ai, an APAC-focused AI-powered watch-to-predict platform led by Mr. Andy Cheung, former Chief Operating Officer of OKX and former Chief Executive Officer of Groupon Hong Kong.
K25.ai is designed to combine artificial intelligence, live-streaming content, creator communities and prediction-based engagement into a watch-to-predict consumer platform for permitted APAC markets. The strategic relationship is intended to provide NewGenIVF with exposure to an emerging category at the intersection of AI-assisted information markets, live-streaming engagement, creator monetization and localized APAC content.
Under the terms of the agreement, NewGenIVF will make an initial strategic investment of US
The closing of the investment, any issuance of NewGenIVF ordinary shares and any exercise of the option remain subject to the terms of the definitive agreements, applicable closing conditions, Nasdaq rules, shareholder approval requirements, if applicable, and other applicable legal and regulatory requirements.
K25.ai: AI-Powered Live-Streaming Prediction Markets
K25.ai is building a new consumer layer for prediction markets by combining real-time content, creator communities, AI-assisted event generation and prediction-based engagement. The platform is designed to allow users in permitted markets to watch live content, follow creators, participate in community discussions and engage with prediction events linked to sports, esports, entertainment, creator challenges, cultural events and other APAC-relevant moments.
K25.ai’s AI layer is intended to support the prediction-market lifecycle, including event discovery, market generation, live-content understanding, data extraction, outcome monitoring and resolution workflows. This model is designed to help creators, communities and event owners launch timely prediction events around live content, while transforming live streaming from passive viewing into a more interactive information market.
Exclusive APAC Agency Partnership
NewGenIVF will enter into an exclusive agency agreement to support the promotion and commercial development of K25.ai in Thailand, Singapore, Japan and other permitted APAC markets, excluding Mainland China, Hong Kong, Macau and other restricted jurisdictions. Under the arrangement, NewGenIVF is expected to earn commission based on gross profit generated from customers it introduces or directly services, creating a potential commercial revenue channel while leveraging the Company’s regional network and commercial relationships.
K25.ai’s products and services will only be made available where legally permitted and, where required, subject to applicable licensing, registration, regulatory approvals or exemptions.
Board Nomination
In connection with the strategic relationship, K25.ai will nominate three independent non-executive director candidates for consideration by NewGenIVF’s board, subject to applicable Nasdaq independence, eligibility, corporate governance, board approval and other legal requirements. Following any such appointments, NewGenIVF expects its board to expand from five to eight directors.
Leadership of K25.ai
K25.ai is led by Mr. Andy Cheung, a veteran technology and digital asset executive with experience scaling platforms across Web3, fintech, consumer internet and digital advertising. Mr. Cheung previously served as Chief Operating Officer of OKX, where he helped build and scale one of the world’s leading digital asset exchanges. He also served as Chief Executive Officer of Groupon Hong Kong and as Head of Hong Kong of iClick Interactive Asia Group Limited, a digital marketing technology company formerly listed on Nasdaq under the ticker ICLK and now operating as Amber International Holding Limited under the ticker AMBR. He was also previously an Independent Director of Prenetics Global Limited, a Nasdaq-listed health sciences company under the ticker PRE.
Strategic Rationale and Market Context
NewGenIVF believes K25.ai is positioned at the intersection of several high-growth themes: AI-powered information markets, live streaming and creator monetization, watch-to-predict audience engagement, AI-assisted event generation and resolution workflows, and localized APAC content and community participation. NewGenIVF believes the investment and agency partnership provide strategic exposure to an emerging category in APAC, where localized prediction-based engagement remains meaningfully underserved compared with larger global markets.
For market-context purposes only, based on selected publicly reported valuation references for larger global prediction-market companies and K25.ai management’s internal analysis, K25.ai’s US
Management Commentary
“This strategic investment provides NewGenIVF with exposure to the convergence of AI, live streaming, creator monetization and prediction-based information markets,” said Mr. Alfred Siu Wing Fung, Founder, Chairman and Chief Executive Officer of NewGenIVF. “K25.ai’s AI-powered watch-to-predict model creates a differentiated way for audiences to engage with live content in permitted APAC markets. The exclusive agency partnership is designed to create commercial opportunities through our regional network, while the investment provides exposure to the long-term development of this emerging category.”
“We are pleased to welcome NewGenIVF as a strategic shareholder and APAC commercial partner,” said Mr. Andy Cheung, Founder of K25.ai. “K25.ai is being built for a new generation of interactive markets, where AI can help convert live content, creator moments and community attention into real-time prediction events. By combining AI-assisted market generation, live streaming, creator-led distribution and localized APAC content, we believe K25.ai can help define the next generation of watch-to-predict information markets in permitted markets.”
Geographic Restrictions
K25.ai is not offered to U.S. persons or to users located in Mainland China, Hong Kong, Macau or other restricted jurisdictions. K25.ai intends to operate in accordance with applicable laws and regulations in the markets where it is made available. K25.ai’s products and services will only be launched or made available in jurisdictions where such activities are legally permitted and, where applicable, subject to required licensing, registration, regulatory approvals or exemptions.
About NewGenIVF Group Limited
NewGenIVF Group is a tech-forward, diversified, multi-jurisdictional growth company pursuing opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through “NewGenProperty,” focused on real estate development projects in the UAE’s Ras Al Khaimah Emirate; “NewGenDigital,” focused on digital asset and DeFi solutions; and “NewGenSup,” focused on health and longevity products and solutions. NewGenIVF’s legacy business involves IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. The information contained on, or accessible through, NewGenIVF’s website is not incorporated by reference into this press release and should not be considered part of this press release.
About K25.ai
K25.ai is an APAC-focused AI-powered live-streaming and watch-to-predict platform. The platform combines real-time content, creator communities, AI-assisted event generation and prediction markets to transform live streaming from passive viewing into an interactive information market. Through K25.ai, users in permitted markets can watch live content, follow creators, participate in community discussions and engage with prediction events linked to real-world outcomes, sports, esports, entertainment, creator challenges and culturally relevant APAC events. K25.ai uses AI-assisted tools to support event creation, content analysis, data extraction, outcome monitoring and resolution workflows. K25.ai is not offered to U.S. persons or to users located in Mainland China, Hong Kong, Macau or other restricted jurisdictions.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995.
These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “outlook,” “would,” “may,” “potential,” and similar statements. Without limiting the generality of the foregoing, forward-looking statements in this press release include, but are not limited to, statements regarding: the strategic investment by the Company in K25.ai, including the entry into and execution of definitive agreements, the anticipated completion of closing, and the satisfaction of closing conditions; the option to invest up to an additional approximately US
These forward-looking statements are based on current expectations, estimates, projections and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, among others, market conditions, regulatory developments (including evolving regulation of prediction-based products, online gaming, digital assets and AI-enabled services in APAC jurisdictions), competition, execution risk, user and creator adoption, platform engagement, liquidity and financing risks, Nasdaq compliance requirements, the ability to satisfy closing conditions, the ability to complete or implement definitive documentation, the risk that definitive agreements may not be entered into on the terms reflected in the binding term sheet or at all, the ability to exercise the option on expected terms or at all, the ability to obtain any required licensing, registration, regulatory approvals or exemptions, the risk that K25.ai or the Company may be unable to offer or commercialize prediction-based products in one or more APAC jurisdictions, the risk that the agency partnership may not generate the level of commissions or revenue currently anticipated by the parties, the risk that K25.ai’s valuation may not be realized and may decline, including in subsequent financing rounds, the risk that any K25.ai-nominated director candidates may not satisfy applicable independence requirements, and the risk that the Company’s broader business strategy across real estate development, digital asset management and reproductive health solutions may not deliver the “sustainable growth” or “high ROI” described in this press release, geographic restrictions and other risks described in the Company’s filings with the U.S. Securities and Exchange Commission.
All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required by applicable law.
Contacts
NewGen Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-3847
Email: NewgenivfIR@icrinc.com
K25.ai Media Contact
media@k25.ai
K25.ai Investor Relations Contact
ir@k25.ai
